Bryan, Garnier & Co's News Retrouvez toute l'actualité de Busineyss®, la plateforme S.A.A.S. dédiée à la gestion de vos landing pages. Thu, 29 Aug 2019 09:54:45 +0200 Zend_Feed_Writer 1.12.0 (http://framework.zend.com) http://www.bryangarnier.com/en contact@bryangarnier.com (Greg Revenu) Greg Revenu Advancing the future of healthcare Thu, 29 Aug 2019 09:54:45 +0200 https://www.bryangarnier.com/en/blog/article/bg-advancing-future-healthcare-brochure https://www.bryangarnier.com/en/blog/article/bg-advancing-future-healthcare-brochure contact@bryangarnier.com (Greg Revenu) Greg Revenu Healthcare Market Update - July 2019 Thu, 29 Aug 2019 09:54:45 +0200 https://www.bryangarnier.com/en/blog/article/bg-healthcare-market-update-july-2019 https://www.bryangarnier.com/en/blog/article/bg-healthcare-market-update-july-2019 contact@bryangarnier.com (Greg Revenu) Greg Revenu Healthcare Market Update - June 2019 Thu, 29 Aug 2019 09:54:45 +0200 https://www.bryangarnier.com/en/blog/article/bg-healthcare-market-update-june-2019 https://www.bryangarnier.com/en/blog/article/bg-healthcare-market-update-june-2019 contact@bryangarnier.com (Greg Revenu) Greg Revenu Bryan, Garnier & Co makes significant move into the Nordics with the acquisition of Beringer Finance Thu, 29 Aug 2019 09:54:45 +0200 https://www.bryangarnier.com/en/blog/article/bg-makes-significant-move-nordics-acquisition-beringer-finance https://www.bryangarnier.com/en/blog/article/bg-makes-significant-move-nordics-acquisition-beringer-finance contact@bryangarnier.com (Greg Revenu) Greg Revenu Bryan, Garnier & Co acts as Joint Bookrunner to Genfit on its $155.4 million Nasdaq Initial Public Offering Thu, 29 Aug 2019 09:54:45 +0200 https://www.bryangarnier.com/en/blog/article/bg-joint-bookrunner-genfit-155-million-nasdaq-ipo https://www.bryangarnier.com/en/blog/article/bg-joint-bookrunner-genfit-155-million-nasdaq-ipo contact@bryangarnier.com (Greg Revenu) Greg Revenu Bryan, Garnier & Co acts a Sole Financial Advisor to Biolectric on the sale of a 60% stake to Ackermans & van Haaren alongside founder and CEO Thu, 29 Aug 2019 09:54:45 +0200 https://www.bryangarnier.com/en/blog/article/bg-sole-financial-advisor-biolecrtic-sale-ackermans-van-haaren https://www.bryangarnier.com/en/blog/article/bg-sole-financial-advisor-biolecrtic-sale-ackermans-van-haaren contact@bryangarnier.com (Greg Revenu) Greg Revenu Healthcare Market Update - March 2019 Thu, 29 Aug 2019 09:54:45 +0200 https://www.bryangarnier.com/en/blog/article/healthcare-market-update-march-2019 https://www.bryangarnier.com/en/blog/article/healthcare-market-update-march-2019 contact@bryangarnier.com (Greg Revenu) Greg Revenu Healthcare Market Update - February 2019 Thu, 29 Aug 2019 09:54:45 +0200 https://www.bryangarnier.com/en/blog/article/healthcare-market-update-february-2019 https://www.bryangarnier.com/en/blog/article/healthcare-market-update-february-2019 contact@bryangarnier.com (Greg Revenu) Greg Revenu Bryan, Garnier & Co acts as Sole Financial Advisor to HighLife on its €32 million Series B Fundraising Thu, 29 Aug 2019 09:54:45 +0200 https://www.bryangarnier.com/en/blog/article/bg-sole-finanacial-advisor-highlife-32million-series-b-fundraising https://www.bryangarnier.com/en/blog/article/bg-sole-finanacial-advisor-highlife-32million-series-b-fundraising contact@bryangarnier.com (Greg Revenu) Greg Revenu Healthcare Market Update - January 2019 Thu, 29 Aug 2019 09:54:45 +0200 https://www.bryangarnier.com/en/blog/article/healthcare-market-update-january-2019 https://www.bryangarnier.com/en/blog/article/healthcare-market-update-january-2019 contact@bryangarnier.com (Greg Revenu) Greg Revenu